Today
Today
@today·5M subscribers·54.4K videos

New study shows how effective immunotherapy is at battling cancer

Posted

April 28, 2025

Views

83,307

Likes

1,176

Comments

107

Engagement

1.54%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Some patients diagnosed with certain types of cancer may soon have the options to skip chemotherapy, radiation and surgery in favor of immunotherapy treatment, according to a new study published in the New England Journal of Medicine. NBC’s Dr. Natalie Azar joins TODAY to break down the findings.

» Subscribe to TODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

Connect with TODAY Online!

Visit TODAY's Website

Find TODAY on Facebook

Follow TODAY on Twitter

Follow TODAY on Instagram

» Stream TODAY All Day

About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.

#health #cancer #immunotherapy

Guests & Subjects Covered

New England JournalTODAY About TODAYFacebook Follow TODAYTwitter Follow TODAY

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

New study shows how effective immunotherapy is at battling cancer · Today · Sentinel